Experimental new rheumatoid arthritis drug passes final phase of human trials - New Atlas

Experimental new rheumatoid arthritis drug passes final phase of human trials  New Atlas

A novel experimental drug is showing promising results from its final phase of human clinical trials. Part of a new class of drugs called JAK-inhibitors, this therapy ...



Comments

Popular posts from this blog

Fibromyalgia — Latest Stories — Pain News Network

Chronic Lyme arthritis: A mystery solved?

Epstein-Barr virus and autoimmune diseases